RSS
Consumer News
Consumer Reports
Trusted reliable news sources from around the web. We offer special news reports, topic news videos, and related content stories. Truly a birds eye view on news.
Consumer Resources
- Details
- Written by Bing News Search Results
- Category: Vehicle News Articles
Edmunds reports on the best value electric cars for 2026, highlighting models like the Chevrolet Bolt EV and Tesla Model 3 for their affordability and features.
Original Image Link
Source:www.charlotteobserver.com
Original Image Link
Source:www.charlotteobserver.com
- Details
- Written by CNET Reviews
- Category: Reviews
If I still had to use a PC running Windows 10, I'd be thrilled that Microsoft is extending its Extended Security Updates program for that operating system until Oct.14, 2027. Its original end-of-life date was Oct.13 of this year.
Photo By CNET
Photo By CNET
- Details
- Written by CNET Reviews
- Category: Reviews
The NotePin S AI wearable, seen here on the wrist of CNET's Katie Collins, could be really useful for my job. And it's on sale for Prime Day. I took over the role of CNET's editorial leader earlier this year, and while I've participated in Prime Day sales as a TV reviewer and general deals…
Photo By CNET
Photo By CNET
- Details
- Written by CNET Reviews
- Category: Reviews
I'm living with two types of Siri assistants right now. There's a cool iOS 27 beta version of Siri AI on my iPhone, and there's Siri Classic on my HomePod. I have to speak to them in different ways. The smarter Siri is not coming to every device you might own. It's also not coming…
Photo By CNET
Photo By CNET
- Details
- Written by Consumer Affairs News
- Category: Consumer Daily Reports
An experimental targeted drug nearly doubled median survival for people with previously treated metastatic pancreatic cancer.
The phase three clinical trial compared the daily pill with standard chemotherapy in nearly 500 patients worldwide.
Researchers say the findings could lead to a new treatment option for patients with few effective alternatives.
Pancreatic cancer is one of the most difficult cancers to treat, especially after it has spread to other parts of the body and stopped responding to initial therapy. For many patients in that situation, treatment options are limited and survival has historically remained short.
Now, a large international clinical trial is offering new hope with an experimental targeted drug that significantly outperformed standard chemotherapy.
The medication, called daraxonrasib, works differently from traditional chemotherapy. Instead of attacking rapidly growing cells, it targets the RAS signaling pathway, which drives the growth of more than 90% of pancreatic cancers.
According to researchers, the study marks the first time a phase three trial has shown such a substantial survival benefit over chemotherapy for patients with previously treated metastatic pancreatic cancer.
For years weve made incremental gains in treating pancreatic cancer, researcher Dr. Zev Wainberg said in a news release.
Now, for the first time, we have demonstrated that targeted inhibition of RAS using an oral inhibitor is changing the landscape of this terrible disease. Seeing this magnitude of benefit in a randomized phase three study is very encouraging for all patients with advanced pancreatic cancer and is a paradigm shift in this deadly disease.
The study
The phase three trial enrolled 479 adults with metastatic pancreatic ductal adenocarcinoma whose cancer had continued growing after one previous course of chemotherapy.
Participants were randomly assigned to receive either a 300-milligram daily dose of daraxonrasib or one of several commonly used chemotherapy treatments selected by their physician.
Researchers followed patients to compare how long they lived overall, how long their cancer remained under control, how their tumors responded to treatment, and how the therapies affected quality of life.
They also monitored side effects throughout the study.
- Details
- Written by Consumer Affairs News
- Category: Consumer Daily Reports
A new Insurify analysis found that Florida, Louisiana, and North Carolina are home to many of the nation's least insurable counties, where homeowners face the highest insurance costs and risks.
The rankings are based on factors including natural disaster risk, home age, property values, and local insurance premiums, all of which influence how expensive and difficult it is to insure a home.
Experts say homeowners can help lower their insurance costs by weather-proofing their homes, shopping around for coverage regularly, and asking insurers about available discounts.
Home insurance has become more expensive and in some parts of the country, it's also becoming much harder to get.
As extreme weather events grow more frequent and costly, insurers are raising rates, limiting coverage, or pulling out of high-risk areas altogether. A new home insurance risk index from Insurify highlights the counties where homeowners are facing the greatest insurance burden, with many of the hardest-hit areas concentrated in Florida, Louisiana, and North Carolina.
To better understand what's driving these trends and what they could mean for homeowners, ConsumerAffairs spoke with Insurify Senior Economic Analyst Matt Brannon about why some counties are becoming increasingly difficult to insure and how climate risk is reshaping the home insurance market.
Identifying risk
Insurify's Home Insurance Risk Index scored more than 3,100 U.S. counties based on factors that influence how difficult and expensive it is to insure a home.
First we look at natural-hazard and extreme-weather risk, Brannon said. Counties with more vulnerability to natural disasters (e.g., wildfires, earthquakes, flooding, hail, etc.) are more prone to frequent and costly insurance claims.
The second factor assessed is the age of a county's housing stock. Because of outdated building codes, worn-down materials, and a lack of regular upkeep, older properties are more susceptible to damage from severe weather. We also look at the number of residential structures in a county and the ratio of residential to commercial structures.
Additionally, we examine the countys median home value, as insurers generally charge higher premiums for more expensive homes, since they are more costly for the insurer to afford to replace.
Consumer Daily Reports Article Count: 5826
Environmental News Articles Article Count: 54
Reviews Article Count: 2885
Vehicle News Articles Article Count: 753
Related Product Search/Búsqueda de productos relacionados
